Altimmune (NASDAQ:ALT – Get Free Report) and Purple Biotech (NASDAQ:PPBT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Profitability This table compares Altimmune and Purple Biotech’s […]
/PRNewswire/ According to Coherent Market Insights, the global osteoarthritis drugs market is estimated to be valued at US$ 8,592.2 million in 2022 and is.
Global Osteoarthritis Drugs Market to surpass US$ 16,184 9 million by 2030 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board").